湖北宜化(000422.SZ):定增事項獲宜昌國資委批覆
格隆匯8月23日丨湖北宜化(000422.SZ)公佈,2022年8月23日,公司收到控股股東宜化集團轉發的宜昌市國資委《關於湖北宜化化工股份有限公司非公開發行A股股票的批覆》(宜市國資產權﹝2022﹞11號),主要內容為:
同意公司非公開發行A股股票,發行數量不超過1.6億股(含),募資總額不超過25億元(含),募資用於潔淨煤加壓氣化多聯產技改搬遷升級項目。宜化集團現金認購總額不低於3億元(含)且不超過5億元(含),發行完後持股比例不低於17.08%且不超過30%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.